GENEVA, Aug. 31 -- MSN LABORATORIES PRIVATE LIMITED, R&D CENTER filed a patent application (IN2026/050323) for “Novel process for the preparation of {(2S)-4-[7-(8-chloronaphthalen-1-yl)-2-{[(2S)-1-methylpyrrolidin-2-yl]-methoxy}-5,6,7,8-tetrahydropyrido[3,4-d] pyrimidin-4-yl]-1-(2-fluoroprop-2-enoyl) piperazin-2-yl} acetonitrile and its intermediates thereof”. With publication no. WO/2026/176492, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07D 401/14

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....